TAIPY / Taisho Pharmaceutical Holdings Co., Ltd. - Depositary Receipt (Common Stock) - Pengajuan SECLaporan Tahunan, Pernyataan Proksi

JPMorgan Chase Bank, N.A. American Depositary Receipt American Depositary Shares Representing Shares of Common Stock of Taisho Pharmaceutical Holdings Co., Ltd. (the "Issuer") (Incorporated under the laws of Japan)

SUBSCRIPTION RIGHTS: Under current Japanese practice offerings of rights to subscribe to additional underlying securities are sometimes made, and in varying amounts, with a subscription price sometimes below the current market price of the security.

Certification under Rule 466

Certification under Rule 466 The depositary, JPMorgan Chase Bank, N.A., represents and certifies the following: (1) That it previously had filed a registration statement on Form F-6 (MonotaRO CO., LTD., 333-236483) that the Commission declared effective, with terms of deposit identical to the terms of deposit of this registration statement. (2) That its ability to designate the date and time of ef

Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, Suite 2405 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 June 21, 2021

Ziegler, Ziegler & Associates LLP Counselors at Law 570 Lexington Avenue, Suite 2405 New York, New York 10022 (212) 319-7600 Telecopier (212) 319-7605 June 21, 2021 JPMorgan Chase Bank, N.

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Taisho Pharmaceutical Holdings Co., Ltd. (Exact name of Issu

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT Under THE SECURITIES ACT OF 1933 For American Depositary Shares Evidenced by American Depositary Receipts Taisho Pharmaceutical Holdings Co., Ltd. (Exact name of Issuer of deposited securities as specified in its charter) Japan (Jurisdiction of Incorporation or organization of Issuer) JPMorgan Chase Bank, N.A

THE BANK OF NEW YORK MELLON FORM OF AMERICAN DEPOSITARY RECEIPT STATEMENT OF TERMS AND CONDITIONS WITH RESPECT TO AMERICAN DEPOSITARY SHARES SHARES OF COMMON STOCK, OF TAISHO PHARMACEUTICAL HOLDINGS COMPANY LTD. (THE “COMPANY”) (INCORPORATED UNDER TH

AMERICAN DEPOSITARY SHARES (One (1) American Depositary Share represents One-fourth (1/4) of one Share) THE BANK OF NEW YORK MELLON FORM OF AMERICAN DEPOSITARY RECEIPT AND STATEMENT OF TERMS AND CONDITIONS WITH RESPECT TO AMERICAN DEPOSITARY SHARES REPRESENTING SHARES OF COMMON STOCK, OF TAISHO PHARMACEUTICAL HOLDINGS COMPANY LTD.

Emmet, Marvin & Martin, LLP Counsellors at Law 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730

EX-4 3 taishoopin.htm OPINION OF DEPOSITARY'S COUNSEL Writer’s Direct Dial EXHIBIT 4 Emmet, Marvin & Martin, LLP Counsellors at Law 120 Broadway New York, New York 10271 (212) 238-3000 (212) 653-1760 Fax: (212) 238-3100 Fax: (212) 653-1730 http://www.emmetmarvin.com 177 Madison Avenue Morristown, New Jersey 07960 (973) 538-5600 Fax: (973) 538-6448 May 11, 2018 The Bank of New York Mellon as Deposi

LZRFY / Localiza Rent A Car SA FORM F-6

As filed with the Securities and Exchange Commission on May 11, 2018 Registration No.

LETTERHEAD OF PATTERSON BELKNAP WEBB & TYLER LLP September 14, 2017

Exhibit (d) LETTERHEAD OF PATTERSON BELKNAP WEBB & TYLER LLP September 14, 2017 Citibank, N.

AMERICAN DEPOSITARY RECEIPT

Exhibit (a) NUMBER AMERICAN DEPOSITARY SHARES CUSIP # Each American Depositary Share represents one-fourth (1/4) of one share of common stock of the Company SUBSCRIPTION RIGHTS: Under Japanese practice offerings of rights to subscribe to additional underlying securities are sometimes made, and in varying amounts, with a subscription price sometimes below the current market price of the security.

Rule 466 Certification

EX-99.(E) 4 e616567ex99-e.htm Exhibit (e) Rule 466 Certification The depositary, Citibank, N.A., represents and certifies the following: 1. That it previously had filed a registration statement on Form F-6 (Registration No. 333-202848), which the U.S. Securities and Exchange Commission declared effective, with terms of deposit identical to the terms of deposit of this Form F-6 Registration Stateme

SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM F-6 REGISTRATION STATEMENT THE SECURITIES ACT OF 1933 FOR DEPOSITARY SHARES EVIDENCED BY AMERICAN DEPOSITARY RECEIPTS TAISHO PHARMACEUTICAL HOLDINGS COMPANY LTD. (Exact name of issuer of

As filed with the Securities and Exchange Commission on September 14, 2017 Registration No.